36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016

• Published in: Critical care (London, England) Vol. 20; no. Suppl 2; p. 94
• Main Authors: Bateman, R. M., Sharpe, M. D., Jagger, J. E., Ellis, C. G., Solé-Violán, J., López-Rodríguez, M., Herrera-Ramos, E., Ruíz-Hernández, J., Borderías, L., Horcajada, J., González-Quevedo, N., Rajas, O., Briones, M., Rodríguez de Castro, F., Rodríguez Gallego, C., Esen, F., Orhun, G., Ergin Ozcan, P., Senturk, E., Ugur Yilmaz, C., Orhan, N., Arican, N., Kaya, M., Kucukerden, M., Giris, M., Akcan, U., Bilgic Gazioglu, S., Tuzun, E., Riff, R., Naamani, O., Douvdevani, A., Takegawa, R., Yoshida, H., Hirose, T., Yamamoto, N., Hagiya, H., Ojima, M., Akeda, Y., Tasaki, O., Tomono, K., Shimazu, T., Ono, S., Kubo, T., Suda, S., Ueno, T., Ikeda, T., Ogura, H., Takahashi, H., Kang, J., Nakamura, Y., Kojima, T., Izutani, Y., Taniguchi, T., O, M., Dinter, C., Lotz, J., Eilers, B., Wissmann, C., Lott, R., Meili, M. M., Schuetz, P. S., Hawa, H., Sharshir, M., Aburageila, M., Salahuddin, N., Chantziara, V., Georgiou, S., Tsimogianni, A., Alexandropoulos, P., Vassi, A., Lagiou, F., Valta, M., Micha, G., Chinou, E., Michaloudis, G., Kodaira, A., Imaizumi, H., De la Torre-Prados, M. V., Garcia-De la Torre, A., Enguix-Armada, A., Puerto-Morlan, A., Perez-Valero, V., Garcia-Alcantara, A., Bolton, N., Dudziak, J., Bonney, S., Tridente, A., Nee, P.
• Format: Journal Article
• Language: English
• Published: England BioMed Central 20-04-2016
• Subjects: Meeting Abstracts
• ISSN: 1466-609X; 1364-8535; 1466-609X
• DOI: 10.1186/s13054-016-1208-6

P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux
R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis
P002 - Lower serum immunoglobulin G2 level does not predispose to severe flu.
J. Solé-Violán, M. López-Rodríguez, E. Herrera-Ramos, J. Ruíz-Hernández, L. Borderías, J. Horcajada, N. González-Quevedo, O. Rajas, M. Briones, F. Rodríguez de Castro, C. Rodríguez Gallego
P003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis
F. Esen, G. Orhun, P. Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. Tuzun
P004 - Adenosine a1 receptor dysfunction is associated with leukopenia: A possible mechanism for sepsis-induced leukopenia
R. Riff, O. Naamani, A. Douvdevani
P005 - Analysis of neutrophil by hyper spectral imaging - A preliminary report
R. Takegawa, H. Yoshida, T. Hirose, N. Yamamoto, H. Hagiya, M. Ojima, Y. Akeda, O. Tasaki, K. Tomono, T. Shimazu
P006 - Chemiluminescent intensity assessed by eaa predicts the incidence of postoperative infectious complications following gastrointestinal surgery
S. Ono, T. Kubo, S. Suda, T. Ueno, T. Ikeda
P007 - Serial change of c1 inhibitor in patients with sepsis – A prospective observational study
T. Hirose, H. Ogura, H. Takahashi, M. Ojima, J. Kang, Y. Nakamura, T. Kojima, T. Shimazu
P008 - Comparison of bacteremia and sepsis on sepsis related biomarkers
T. Ikeda, S. Suda, Y. Izutani, T. Ueno, S. Ono
P009 - The changes of procalcitonin levels in critical patients with abdominal septic shock during blood purification
T. Taniguchi, M. O
P010 - Validation of a new sensitive point of care device for rapid measurement of procalcitonin
C. Dinter, J. Lotz, B. Eilers, C. Wissmann, R. Lott
P011 - Infection biomarkers in primary care patients with acute respiratory tract infections – Comparison of procalcitonin and C-reactive protein
M. M. Meili, P. S. Schuetz
P012 - Do we need a lower procalcitonin cut off?
H. Hawa, M. Sharshir, M. Aburageila, N. Salahuddin
P013 - The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteria
V. Chantziara, S. Georgiou, A. Tsimogianni, P. Alexandropoulos, A. Vassi, F. Lagiou, M. Valta, G. Micha, E. Chinou, G. Michaloudis
P014 - Changes in endotoxin activity assay and procalcitonin levels after direct hemoperfusion with polymyxin-b immobilized fiber
A. Kodaira, T. Ikeda, S. Ono, T. Ueno, S. Suda, Y. Izutani, H. Imaizumi
P015 - Diagnostic usefullness of combination biomarkers on ICU admission
M. V. De la Torre-Prados, A. Garcia-De la Torre, A. Enguix-Armada, A. Puerto-Morlan, V. Perez-Valero, A. Garcia-Alcantara
P016 - Platelet function analysis utilising the PFA-100 does not predict infection, bacteraemia, sepsis or outcome in critically ill patients
N. Bolton, J. Dudziak, S. Bonney, A. Tridente, P. Nee
P017 - Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients
G. Nicolaes, M. Wiewel, M. Schultz, K. Wildhagen, J. Horn, R. Schrijver, T. Van der Poll, C. Reutelingsperger
P018 - Il-8: is this a more reliable biomarker for sepsis severity than CRP, Procalcitonin, E-selectin, IL-6 and TNF-[alpha]
S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans
P019 - Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study
E. G. Gayat, J. Struck, A. Cariou, N. Deye, B. Guidet, S. Jabert, J. Launay, M. Legrand, M. Léone, M. Resche-Rigon, E. Vicaut, A. Vieillard-Baron, A. Mebazaa
P020 - Impact of disease severity assessment on performance of heparin-binding protein for the prediction of septic shock
R. Arnold, M. Capan, A. Linder, P. Akesson
P021 - Kinetics and prognostic value of presepsin (sCD14) in septic patients. A pilot study
M. Popescu, D. Tomescu
P022 - Comparison of CD64 levels performed by the facs and accellix systems
C. L. Sprung, R. Calderon Morales, G. Munteanu, E. Orenbuch-Harroch, P. Levin, H. Kasdan, A. Reiter, T. Volker, Y. Himmel, Y. Cohen, J. Meissonnier
P023 - Diagnosing sepsis in 5 minutes: Nanofluidic technology study with pancreatic-stone protein (PSP/ reg)
L. Girard, F. Rebeaud
P024 - How nanotechnology-based approaches could contribute to sepsis prevention, diagnosis and treatment
I. Herrmann
P025 - Il7r transcriptional expression analysis during septic shock
B. Delwarde, E. Peronnet, E. Cerrato, F. Venet, A. Lepape, T. Rimmelé, G. Monneret, J. Textoris
P026 - Disbalance of microbial metabolites of aromatic acids affects the severity in critically ill patients
N. Beloborodova, V. Moroz, A. Osipov, A. Bedova, Y. Sarshor, A. Pautova, A. Sergeev, E. Chernevskaya
P027 - Copeptin predicts 10-year all-cause mortality in community patients
J. Odermatt, R. Bolliger, L. Hersberger, M. Ottiger, M. Christ-Crain, B. Mueller, P. Schuetz
P028 - Identification of differential proteomic response in septic patients secondary to community and hospital acquired pneumonia
N. K. Sharma, A. K. Tashima, M. K. Brunialti, F. R. Machado, M. Assuncao, O. Rigato, R. Salomao
P029 - Monocyte HLA-DR expression in community-acquired bacteremic sepsis - dynamics associated to aetiology and prediction of secondary sepsis
S. C. Cajander, G. Rasmussen, E. Tina, B. Söderquist, J. Källman, K. Strålin
P030 - Soluble B- and T-lymphocyte attenuator: A possible prognostic marker in sepsis
A. L. Lange, J. S. Sundén-Cullberg, A. M. Magnuson, O. H. Hultgren
P031 - Fractal dimension: A new biomarker for quantifying clot microstructure in patients across the sepsis spectrum
G. Davies, S. Pillai, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans
P032 - Comparison between the new biomarker for coagulation, clot microstructure (Df) with rotational thromboelastometry (ROTEM) in patients across the sepsis spectrum
S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans
P033 - Changes in fibrinolysis across the sepsis spectrum: The use of rotational thromboelastometry (ROTEM) lysis index (LI60) and D-Dimer concentration
S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans
P034 - The intensive care infection score – a promising marker for the prediction of infection and its severity.
P. Van der Geest, M. Mohseni, J. Linssen, R. De Jonge, S. Duran, J. Groeneveld
P035 - Challenges in the clinical diagnosis of sepsis
R. Miller III, B. K. Lopansri, L. C. McHugh, A. Seldon, J. P. Burke
P036 - Does zero heat flux thermometry more accurately identify sepsis on intensive care?
J. Johnston, R. Reece-Anthony, A. Bond, A. Molokhia
P037 - Advancing quality (AQ) sepsis programme: Improving early identification & treatment of sepsis in North West England.
C. Mcgrath, E. Nsutebu
P038 - Prehospital transport of acute septic patients
P. Bank Pedersen, D. Pilsgaard Henriksen, S. Mikkelsen, A. Touborg Lassen
P039 - Vasodilatory plant extracts gel as an alternative treatment for fever in critically ill patients
R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei
P040 - Host response and outcome of hypothermic sepsis
M. A. Wiewel, M. B. Harmon, L. A. Van Vught, B. P. Scicluna, A. J. Hoogendijk, J. Horn, A. H. Zwinderman, O. L. Cremer, M. J. Bonten, M. J. Schultz, T. Van der Poll, N. P. Juffermans, W. J. Wiersinga
P041 - Septic shock alert over SIRS criteria has an impact on outcome but needs to be revised
G. Eren, Y Tekdos, M. Dogan, O. Acicbe, E. Kaya, O. Hergunsel
P042 - Association between previous prescription of βblockers and mortality rate among septic patients: A retrospective observational study
S. Alsolamy, G. Ghamdi, L. Alswaidan, S. Alharbi, F. Alenezi, Y. Arabi
P043 - Recognition and treatment of sepsis on labour ward– teaching & information resources can improve knowledge
J. Heaton, A. Boyce, L. Nolan, J. Johnston, A. Dukoff-Gordon, A. Dean, A. Molokhia
P044 - Culture negative sepsis in the ICU – what is unique to this patient population?
T. Mann Ben Yehudah
P045 - Organ dysfunction in severe sepsis patients identified in administrative data in Germany, 2007-2013
C. Fleischmann, D. Thomas-Rueddel, C. Haas, U. Dennler, K. Reinhart
P046 - A comparison of residents’ knowledge regarding; the Surviving Sepsis Campaign 2012 guideline
O. Suntornlohanakul, B. Khwannimit
P047 - Effectiveness of a septic shock bundle to improve outcomes in the ICU
F. Breckenridge, A. Puxty
P048 - Dose of norepinephrine in the first 24 hours as a parameter evaluating the effectiveness of treatment in patients with severe sepsis and septic shock
P. Szturz, P. Folwarzcny, J. Svancara, R. Kula, P. Sevcik
P049 - Norepinephrine or vasopressin + norepinephrine in septic shock. A retrospective series of 39 patients
L. Caneva, A. Casazza, E. Bellazzi, S. Marra, L. Pagani, M. Vetere, R. Vanzino, D. Ciprandi, R. Preda, R. Boschi, L. Carnevale
P050 - Methylene blue effectiveness as contributory treatment in patients with septic shock
V. Lopez, M. Aguilar Arzapalo, L. Barradas, A. Escalante, J. Gongora, M. Cetina
P051 - Coagulation disorders in patients with severe sepsis and DIC evaluated with thromboelastometry.
B Adamik, D Jakubczyk, A Kübler
P052 - Frequency and outcome of early sepsis-associated coagulopathy
A. Radford, T. Lee, J. Singer, J. Boyd, D. Fineberg, M. Williams, J. Russell
P053 - Assessment of coagulopathy in cancer patients with severe sepsis or septic shock. A case-control pilot study
E. Scarlatescu, D. Tomescu, G. Droc, S. Arama
P054 - Thromboelastometry in critically ill patients with disseminated intravascular coagulation
M. Müller, M. Straat, S. S. Zeerleder, N. P. Juffermans
P055 - Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortality rates in severe sepsis and septic shock
C. F. Fuchs, C. S. Scheer, S. W. Wauschkuhn, M. V. Vollmer,